期刊文献+

绝经对女性冠心病患者临床特征及危险因素的影响 被引量:18

Effects of menopause on clinical profile and cardiovascular risk factors of women with coronary heart disease
下载PDF
导出
摘要 目的探讨绝经对女性冠心病患者临床特征及危险因素的影响。方法选择2009年2月至2011年1月在我院经冠脉造影确诊的未绝经冠心病患者(29例);年龄相匹配的男性患者(31例);绝经后女性冠心病患者(67例),其中绝经时间≤5年者30例,绝经时间>5年者37例;健康绝经者(60例),其中绝经时间≤5年者30例,绝经时间>5年者30例进行对比分析。结果与男性比较,未绝经组糖代谢异常及有冠心病家族史明显高于男性组(P<0.05),且多数具有典型的心绞痛。绝经各组与未绝经组比较随着绝经时间的延长合并高血压者显著升高(P<0.01)。而合并糖代谢异常及有冠心病家族史者下降,同时表现为典型心绞痛者也明显下降(P<0.05)。冠状动脉病变女性以单支病变为主(P<0.05)。绝经后冠心病者较绝经≤5年健康组,雌二醇及孕酮水平均下降明显(P<0.05),随着绝经时间的延长雌二醇下降尤为明显,而绝经后的冠心病组间无差异。结论心血管危险因素、临床特征两性存在差异,绝经对女性冠心病患者心血管危险因素及冠状动脉病变有影响,雌孕激素水平下降可能是其原因之一。 Objective To study the effects of menopause on clinical profile and risk factors of women with coronary heart disease(CHD).Methods Risk factors,clinical symptoms and coronary angiographic characteristics of CHD were investigated retrospectively in the following subjects who came to our hospital between February 2009 and January 2011: 29 premenopausal women with CHD,31 age-matched male patients(control group),67 postmenopausal women with CHD(30 whose menopause lasted 5 years or less and 37 whose menopause lasted more than 5 years),and 60 healthy postmenopausal women(30 whose menopause lasted 5 years or less and 30 whose menopause lasted more than 5 years).Results Compared with the men,abnormal metabolism of sugar and family history of CHD were significantly higher in premenopausal group than in male group(P<0.05),and most of them in premenopausal group had typical angina.Compared with premenopausal group,a significantly increased number of patients in postmenopausal groups had hypertension as menopause prolonged(P<0.01);meanwhile,the number of patients with abnormal metabolism,family history of CHD and typical angina markedly reduced(P<0.05).Coronary artery disease was primarily a single lesion in women(P<0.05).The level of estrogen and progesterone declined after menopause in menopausal CHD groups than in the healthy group with menopause for less than years(P<0.05);progesterone level dropped especially significantly as menopause prolonged.However,no such difference was found between CHD groups after menopause.Conclusion Males and females have different cardiovascular risk factors and clinical profile.Menopause affects cardiovascular risk factors and coronary artery lesions in female CHD patients,and the decline of estrogen and progesterone level is probably one of the causes.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第3期321-323,343,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 冠心病 临床特征 绝经女性 雌激素 危险因素 coronary heart disease clinical profile menopausal woman estrogen cardiovascular risk factors
  • 相关文献

参考文献8

  • 1JOHANNES J,BAIREY CN. Is cardiovascular disease in women inevitable? preparing for menopause and beyond[J].Cardiology in Review,2011,(03):76-80.
  • 2刘倩竹,刘梅林.女性冠心病的特点[J].心血管病学进展,2011,32(2):146-148. 被引量:11
  • 3PINA IL. Cardiovascular diseae in women:challenge of the middle years[J].Cardiology in Review,2011,(19):71-75.
  • 4叶平,周必业.他汀在女性心血管疾病一级预防中的作用[J].心血管病学进展,2011,32(2):152-154. 被引量:4
  • 5LOVLIEN M,SCHEI B,GJENGEDAL E. Are there gender differences related to symptoms of acute myocardial infarction? A Norwegian perspective[J].Progress in Cardiovascular Nursing,2006,(01):14-19.
  • 6JONSDOTTIR LS,SIGFUSSON N,SIGNVALDASON H. Incidence and prevalence of recognized and unrecognized myocardial infarction in women[J].European Heart Journal,2000,(07):1011-1018.
  • 7HERRINGTON DM. The HERS trial results:paradigms lost? heart and estrogen progestin replacement study[J].Annals of Internal Medicine,1999,(06):463-466.
  • 8HOIBRAATEN EO,SELJEFO IA,NDERSEN TO. The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease:results from the estrogen in women with atherosclerosis study[J].Thrombosis Research,2000,(01):19-27.

二级参考文献15

  • 1王小艳.经皮冠脉介入治疗在非ST段抬高急性心肌梗死或非稳定型心绞痛不同性别患者中的比较[J].中国处方药,2006,5(11):27-27. 被引量:12
  • 2Johannes J, Bairey Merz CN. Is cardiovascular disease in women inevitabie? preparing for menopause and beyond [ J ]. Cardiol Rev,2011,19 :76-80.
  • 3Tziomalos K, Kakafika AI, Athyros VG, et al. The role of statins for the prima- ry and secondary prevention of coronary heart disease in women [ J ]. Curt Pharm Des ,2009,15 : 1054-1062.
  • 4Pina IL. Cardiovascular disease in women: challenge of the middle years [ J ]. Cardiol Rev, 2011,19:71-75.
  • 5Price JA. Management and prevention of cardiovascular disease in women[ J]. Nurs Clin North Am ,2004,39:873-884.
  • 6Kakafika AI, Athyros VG, Tziomalos K, et at. Primary and secondary coronary heart disease prevention using statins : is targeting Adam or Eve equally effective [ J] ? Expert Opin Pharmacother, 2008,9 : 1437-1440.
  • 7Bukkapatnam RN, Gabler NB, Lewis WR. Statins for primary prevention of car- diovascular mortality in women: a systematic review and meta-analysis [ J ]. Prev Cardio1,2010,13:84-90.
  • 8No authors listed. West of Scotland Coronary Prevention Study: implications for clinical practice. The WOSCOPS Study Group[ J]. Eur Heart J, 1996,17 : 163- 164.
  • 9Gotto AM Jr. Establishing the benefit of statins in low-to-moderate-risk primary prevention: the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) [ J ]. Atheroscler Suppl,2007,8:3 -8.
  • 10Nakamura H. Primary prevention trial by lowering hyperlipidemia on the cardio- vascular disease (MEGA Study) [ J ]. Nippon Ronen Igakkai Zasshi,2009,46: 18-21.

共引文献13

同被引文献99

引证文献18

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部